ANL 11.20 Increased By ▲ 0.08 (0.72%)
ASC 9.55 Decreased By ▼ -0.10 (-1.04%)
ASL 11.30 Increased By ▲ 0.04 (0.36%)
AVN 76.18 Increased By ▲ 1.77 (2.38%)
BOP 5.80 Increased By ▲ 0.03 (0.52%)
CNERGY 5.25 Decreased By ▼ -0.03 (-0.57%)
FFL 6.94 Increased By ▲ 0.03 (0.43%)
FNEL 6.14 Increased By ▲ 0.09 (1.49%)
GGGL 11.89 Decreased By ▼ -0.05 (-0.42%)
GGL 16.25 Increased By ▲ 0.12 (0.74%)
GTECH 9.30 Increased By ▲ 0.19 (2.09%)
HUMNL 6.43 Decreased By ▼ -0.11 (-1.68%)
KEL 2.53 Increased By ▲ 0.01 (0.4%)
KOSM 3.09 Increased By ▲ 0.08 (2.66%)
MLCF 26.85 Increased By ▲ 0.55 (2.09%)
PACE 3.05 Increased By ▲ 0.01 (0.33%)
PIBTL 5.96 Decreased By ▼ -0.03 (-0.5%)
PRL 16.45 Decreased By ▼ -0.15 (-0.9%)
PTC 7.80 Increased By ▲ 0.30 (4%)
SILK 1.39 Increased By ▲ 0.02 (1.46%)
SNGP 25.96 Increased By ▲ 0.16 (0.62%)
TELE 11.04 Increased By ▲ 0.29 (2.7%)
TPL 9.32 Increased By ▲ 0.02 (0.22%)
TPLP 16.50 Decreased By ▼ -0.15 (-0.9%)
TREET 28.90 No Change ▼ 0.00 (0%)
TRG 79.35 Increased By ▲ 0.95 (1.21%)
UNITY 22.28 Increased By ▲ 0.07 (0.32%)
WAVES 13.19 Increased By ▲ 0.24 (1.85%)
WTL 1.54 No Change ▼ 0.00 (0%)
YOUW 5.15 Increased By ▲ 0.05 (0.98%)
BR100 4,172 Increased By 8.7 (0.21%)
BR30 15,038 Increased By 136.3 (0.91%)
KSE100 42,071 Increased By 58.2 (0.14%)
KSE30 15,943 Increased By 29.8 (0.19%)
Business & Finance

CureVac says interest in its COVID-19 vaccine on the rise

  • The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.
  • Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.
Updated 15 Apr, 2021

FRANKFURT: German biotech firm CureVac said it had seen the number of requests for its experimental COVID-19 vaccine increase over the past few days, following a halt of the use of Johnson & Johnson's shot amid concerns over rare side effects.

The European Union in November secured up to 405 million doses of CureVac's two-shot vaccine, which has yet to win regulatory approval, the company's only large supply contract so far.

A spokesman said requests have been coming in from various actors, including governments and international organisations but he declined to elaborate. The group is to hold an analyst call on fourth-quarter results at 1400 GMT.

Europe's choppy vaccine rollout hit more trouble this week after J&J suspended shipments of its COVID-19 shot and Denmark said it would drop a similar vaccine from AstraZeneca over very rare cases of blood clotting.

Comments

Comments are closed.